159 related articles for article (PubMed ID: 28500312)
21. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
[No Abstract] [Full Text] [Related]
22. Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas.
Woo CG; Sung CO; Choi YM; Kim WG; Kim TY; Shong YK; Kim WB; Hong SJ; Song DE
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S728-33. PubMed ID: 26077913
[TBL] [Abstract][Full Text] [Related]
23. Impact of tumor size on subclinical central lymph node metastasis in papillary thyroid microcarcinoma depends on age.
Kim JY; Jung EJ; Park T; Jeong SH; Jeong CY; Ju YT; Lee YJ; Hong SC; Choi SK; Ha WS
World J Surg Oncol; 2015 Feb; 13():88. PubMed ID: 25886181
[TBL] [Abstract][Full Text] [Related]
24. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
25. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
27. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection.
Wada N; Duh QY; Sugino K; Iwasaki H; Kameyama K; Mimura T; Ito K; Takami H; Takanashi Y
Ann Surg; 2003 Mar; 237(3):399-407. PubMed ID: 12616125
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.
Zhao C; Jiang W; Gao Y; Niu W; Zhang X; Xin L
J Int Med Res; 2017 Jun; 45(3):1221-1230. PubMed ID: 28534700
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma.
Park JP; Roh JL; Lee JH; Baek JH; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Am J Surg; 2014 Sep; 208(3):412-8. PubMed ID: 24602323
[TBL] [Abstract][Full Text] [Related]
30. [Factors for lymph node metastasis and survival rate in papillary thyroid microcarcinoma: from a large cohort of 3 607 cases series].
Xu L; Xu YN; Wang JD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 52(4):267-272. PubMed ID: 28441803
[No Abstract] [Full Text] [Related]
31. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
[TBL] [Abstract][Full Text] [Related]
32. Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?
Moon HJ; Kim EK; Chung WY; Yoon JH; Kwak JY
Ann Surg Oncol; 2011 Jul; 18(7):1916-23. PubMed ID: 21267788
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
[TBL] [Abstract][Full Text] [Related]
34. Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy.
Lee YS; Lim H; Chang HS; Park CS
J Korean Med Sci; 2014 May; 29(5):676-9. PubMed ID: 24851024
[TBL] [Abstract][Full Text] [Related]
35. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features of papillary thyroid microcarcinoma with a diameter less than or equal to 5 mm.
Yan L; Blanco J; Reddy V; Al-Khudari S; Tajudeen B; Gattuso P
Am J Otolaryngol; 2019; 40(4):560-563. PubMed ID: 31103218
[TBL] [Abstract][Full Text] [Related]
37. An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma.
Tran B; Roshan D; Abraham E; Wang L; Garibotto N; Wykes J; Campbell P; Ebrahimi A
J Clin Endocrinol Metab; 2018 Jun; 103(6):2199-2206. PubMed ID: 29672723
[TBL] [Abstract][Full Text] [Related]
38. Managing thyroid microcarcinomas.
Mazzaferri EL
Yonsei Med J; 2012 Jan; 53(1):1-14. PubMed ID: 22187228
[TBL] [Abstract][Full Text] [Related]
39. [Risk Factors for central lymph node metastasis in 1 988 papillary thyroid microcarcinoma patients].
Li XJ; Yang L; Ma BL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):52-57. PubMed ID: 29774686
[No Abstract] [Full Text] [Related]
40. Papillary thyroid microcarcinomas located at the middle part of the middle third of the thyroid gland correlates with the presence of neck metastasis.
Xiang D; Xie L; Xu Y; Li Z; Hong Y; Wang P
Surgery; 2015 Mar; 157(3):526-33. PubMed ID: 25433730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
